One structure will be owned by Ed and Beatriz Schweitzer, one will be owned by Schweitzer Engineering Laboratories ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

After years of stripping away services to the west side, Ald. Janessa Wilkins calls Mercy's latest move "like the re-opening ...

Hangar A recognized for its unified express delivery platform and ability to help brands scale with speed, visibility, and control. Visibility is the number one reason customers choose Hangar A over ...

A new hanger capable of holding 10 small planes is coming to Concord Municipal Airport in response to a widespread push for more private aviation facilities.

United Therapeutics Corporation made $24.64 a share (GAAP) on $2.88 billion in FY2024. The current analyst firm consensus has profits increasing to $27.68 a share as sales climb to $3.22 billion ...

United Therapeutics had a net margin of 40.31% and a return on equity of 19.22%. The firm’s revenue was up 17.2% compared to the same quarter last year.

United Therapeutics has a 12-month low of $221.53 and a 12-month high of $417.82. The company has a market capitalization of $14.28 billion, a price-to-earnings ratio of 14.05, a price-to-earnings ...

The startup has not accepted any venture capital, Clark was adamant to point out. “We skipped over the VC because we had a customer out of the gates, and it was United Therapeutics,” Clark said.

Dec. 16—United Therapeutics Corp., a Maryland-based biotechnology company with an artificial organ manufacturing research facility in Manchester's Millyard, says it's no longer pursuing plans ...